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Abstract
Background: To investigate different responses to a high-fat/cholesterol diet and uncover their
underlying genetic factors between C57BL/6J (B6) and DBA/2J (D2) inbred mice.
Methods: B6 and D2 mice were fed a high-fat/cholesterol diet for a series of time-points. Serum
and bile lipid profiles, bile acid yields, hepatic apoptosis, gallstones and atherosclerosis formation
were measured. Furthermore, a whole genome microarray was performed to screen hepatic genes
expression profile. Quantitative real-time PCR, western blot and TUNEL assay were conducted to
validate microarray data.
Results: After fed the high-fat/cholesterol diet, serum and bile total cholesterol, serum cholesterol
esters, HDL cholesterol and Non-HDL cholesterol levels were altered in B6 but not significantly
changed in D2; meanwhile, biliary bile acid was decreased in B6 but increased in D2. At the same
time, hepatic apoptosis, gallstones and atherosclerotic lesions occurred in B6 but not in D2. The
hepatic microarray analysis revealed distinctly different genes expression patterns between B6 and
D2 mice. Their functional pathway groups included lipid metabolism, oxidative stress, immune/
inflammation response and apoptosis. Quantitative real time PCR, TUNEL assay and western-blot
results were consistent with microarray analysis.
Conclusion: Different genes expression patterns between B6 and D2 mice might provide a
genetic basis for their distinctive responses to a high-fat/cholesterol diet, and give us an opportunity
to identify novel pharmaceutical targets in related diseases in the future.
Background
Western-type/high-fat diets are a well-established risk fac-
tor for both atherosclerosis and gallstones, due to the con-
sequent high levels of circulating [1] or biliary cholesterol
[2]. The liver is an essential organ in maintaining choles-
terol homeostasis because of its capability to clear exces-
sive cholesterol from blood through direct excretion into
the bile [3] or the bile acid synthesis pathway [4]. Altera-
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tion in cholesterol homeostasis may lead to accumulation
of excessive cholesterol in bodies and deleterious conse-
quences. Elevated blood cholesterol levels, especially
LDL, will eventually lead to atherosclerosis [5]. At the
same time, hypersecretion of cholesterol into bile is a pre-
requisite for gallstones formation [6]. In addition, accu-
mulating data have suggested that genetics plays a pivotal
role in cholesterol homeostasis and subsequent gallstones
formation and atherosclerosis. For instance, mutation of
ABCG5/G8 (ATP-binding cassette, sub-family G
(WHITE), member 5/8) limits biliary excretion of sterols
and alters susceptibility to gallstones and atherosclerosis
[7].
Inbred mice strains have been a powerful force in eluci-
dating the genetic basis of human physiology and patho-
physiology [8]. When fed to a high-fat/cholesterol diet,
inbred mice strains show varying susceptibilities to
atherosclerosis and gallstones respectively. C57BL/6J (B6)
mice are susceptible and DBA/2J (D2) mice are resistant
to both atherosclerosis and gallstones [9-11]. The analysis
of differences in the responsiveness among inbred strains
to high-fat/cholesterol diets is leading to new insights into
associated diseases including atherosclerosis, diabetes,
obesity and gallstones [11]. Although researchers have
exerted great efforts using genetic tools to illuminate the
genetic factors underlying the different responses to high-
fat/cholesterol diets between inbred mice strains [12], the
mechanisms have not been clearly elucidated. In the past
decades, microarray technology has provided a powerful
tool to study genetic and molecular events in complex dis-
eases [13]. Here, studies were designed to examine the
dynamically different responses to a high-fat/cholesterol
diet between C57BL/6J (B6) and DBA/2J (D2) inbred
mice, and uncover the underlying genetic factors using
Affymetrix microarray technology as well. This may pro-
vide us an opportunity to predict the risks of developing
high-fat diets related diseases, and construct a basis for
identification of candidate genes in humans.
Methods
Animals and Diets
Six weeks-old B6 and D2 female mice were purchased
from Shanghai SLAC Laboratory Animal CO. LTD, China,
and maintained in temperature and humidity-controlled
room. Mice were fed a high-fat/cholesterol diet
(0.5%cholic acid, 1.25%cholesterol and 15%fat) for
0(control), 1, 4, 12 and 21 weeks respectively, with 10
mice of each strain for each time point. Blood was col-
lected through inferior cava veins. Biliary bile was aspi-
rated from the gallbladder with sterile injectors. All
procedures were approved by the Institutional Animal
Care and Use Committee of Shanghai Institutes for Bio-
logical Science.
Serum and bile cholesterol assay
Serum and bile total cholesterol (TC), HDL-cholesterol
and Biliary total bile acid levels were assayed using a Total
Cholesterol Kit, HDL-Cholesterol Kit and Total Bile Acids
Kit (Shenzhen Mindray Bio-Medical Electronics Co., Ltd,
China). Serum cholesterol esters were assayed using High
Performance Liquid Chromatography (HPLC) in Shang-
hai Institute of Organic Chemistry, Chinese Academy of
Sciences.
Evaluation of atherosclerotic lesions and gallstones
Hearts containing upper sections of the aorta were col-
lected and evaluation of aortic lesions was performed
using the Oil-red O method described by Beverly Paigen
[14]. Briefly, every other 10 μm section of aortic sinus was
fixed on polylysine-coated microscope slides and stained
with Oil-red O. Aortic surface lesion sizes were evaluated
by using the grid on the microscope eyepiece and pre-
sented as μm2. Gallstones formation was detected by
naked eyes and described as the percentage of stone pres-
ence among mice of the same group. Gallstones in the
same group at each time-point were pooled and weighed.
Liver tissues RNA Extraction and microarray experiments
Liver tissues were removed from mice and stored in liquid
nitrogen until use. Total RNA was extracted by using Tri-
zol reagent (Invitrogen) according to the manufacturer's
instructions, and purified by using a RNeasy Mini Kit
(Qiagen). RNA samples of each group were then used to
generate biotinylated cRNA targets for the Affymetrix
GeneChip Mouse Genome 430 2.0 Array, which con-
tained 39000 transcripts. All experiments were performed
by following the protocol of Affymetrix Inc.
After hybridization, arrays were stained in the Fluidics Sta-
tion 450 and scanned on the Affymetrix Scanner 3000.
Fluorescent signal intensities for all spots on the arrays
were analyzed using the Gene Chip Operating System
(GCOS; Affymetrix). Ratios were calculated between 0
week and the rest of time points within the same mouse
strain, and then between two strains at each of five time
points. Genes with a fold change of at least 2 were selected
for further analysis. Hierarchical analysis was performed
using Cluster 3.0 to define the genes expression patterns.
Furthermore, the selected genes were grouped in func-
tional categories based on Gene Ontology database (GO:
http://www.geneontology.org/), and functional pathways
(KEGG and BIOCARTA) were also analyzed by using
DAVID 2007.
Quantitative real-time polymerase chain reaction (QRT-
PCR)
To validate microarray data, QRT-PCR was performed for
every mouse at each time point of two strains. It was oper-Nutrition & Metabolism 2009, 6:43 http://www.nutritionandmetabolism.com/content/6/1/43
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ated on an ABI 7900 instrument with gene-specific prim-
ers and SYBR Green PCR Master Mix (Applied Biosystems)
according to the manufacturer's recommendation. Reac-
tion conditions are available on request. The PCR primers
used in this study are listed at Table S1 in Additional file 1.
TUNEL Assay and Western blot analysis
Apoptosis of liver cells was detected by immunohisto-
chemical TUNEL (Terminal Transferase dUTP Nick End
Labeling) assay using in situ cell death detection kit, Fluo-
rescein (Roche). Formalin-fixed liver tissues were embed-
ded in OCT compound for cryostat sectioning, and 5-μm
sections were fixed on polylysine-coated microscope
slides for TUNEL assay according to the manufacturer's
instructions. Sections were analyzed under a fluorescence
microscope (objective ×20). Positively stained nuclei of
liver cells were counted for analysis.
Liver tissues were homogenized and proteins were
extracted by using RIPA Lysis Buffer (Beyotime Institute of
Biotechnology, China) containing Phosphatase Inhibitor
Cocktail Tablets (Roche) according to the manufacturer's
instructions. Western blot was performed according to the
methods described previously [15]. Antibodies to
Hspa1b, Parp and Cyp7a1 were commercially obtained
from Abcam (Cambridge, MA), Cell Signaling Technology
(Beverly, MA) and Santa Cruz Biotechnology, separately.
Statistical Analysis
All values were presented as mean ± SD. Statistical analy-
sis was performed using ANOVA and the Student's t test,
and p < 0.05 was considered significantly different.
Results
Dynamic distribution of cholesterol in serum and bile and 
bile acid yields
As shown in Figure 1, after fed the high-fat/cholesterol
diet, serum total cholesterol (TC) levels in B6 mice
increased as early as the 1st week and reached their peaks
at 12 weeks. Non-HDL and cholesteryl linoleate choles-
terol levels also reached their peaks at 12 weeks. However,
the HDL cholesterol level decreased after the 12th week. In
contrast, these cholesterol levels did not significantly
change in D2 mice.
As total cholesterol levels in serum increased, the bile total
cholesterol levels in B6 mice also significantly increased as
early as the 1st week, with its peak at four weeks. However,
biliary bile acid levels decreased in B6 mice and increased
in D2 mice after the 4th week.
Gallstones and atherosclerotic lesions development
The two strains considerably differed in the prevalence of
gallstones. We observed that 10% of B6 mice developed
gallstones as early as the 4th week, when bile cholesterol
concentration had reached its peak, while bile acids
decreased after. The gallstone percentage increased to 80%
at 12 weeks and reached 100% at 21 weeks, when bile
cholesterol was maintained at higher levels. The weights
of gallstones were also distinctly increased after the 4th
week. However, atherosclerotic lesions were observed
only at 21 weeks. Of note, Oil-red O stained lesions (7800
± 211 μm2) were present in aortas of all B6 mice at 21
weeks. In contrast, neither atherosclerotic lesions nor gall-
stones formation was detected in D2 mice at any time
point. See Figure S1 in Additional file 2 for details.
Gene expression profile and pathway analysis
Using the 2-fold change cutoff, we identified 1191 genes
for further analysis including 1051 known genes and 140
ESTs. Detailed information of these genes was listed at
Table S2 in Additional file 3. The overall functional cate-
gories of these genes were grouped into transcription reg-
ulation, protein modification, transport, cell cycle/
adhesion/apoptosis, signal transduction, immune
response/inflammation, lipid metabolism, cell metabo-
lism, development, RNA processing and others or
unknown function (See Figure S2 in Additional file 4).
Using hierarchical cluster analysis, we observed that the
two inbred mice strains had distinctly different genes
expression patterns. Most of the genes up-regulated or
down-regulated in B6 mice might have the opposite pat-
terns in D2 mice (Figure 2A).
To examine whether there was recognizable biological rel-
evance to the genes expression patterns, further functional
pathway analysis was performed. Using the combination
of GO, KEGG and BIOCARTA, we observed that genes
were involved in several key functional pathway groups
such as lipid metabolism, oxidative stress, immune
response/inflammation and cell apoptosis.
We observed that multiple lipid metabolism genes were
differentially expressed between B6 and D2 mice. For
instance, genes Abca1 (ATP-binding cassette sub-family A
member 1), Abcg5, Abcg8 and  Soat2  (sterol O-
acyltransferrase2) were up-regulated in B6 mice but
unchanged in D2 mice. Soat1 (sterol O-acyltransferase1)
were up-regulated in B6 mice but down-regulated in D2
mice.Cyp7a1  (cytochrome P450 family 7 subfamily a
polypeptide 1) and Cyp8b1 (cytochrome P450 family 8
subfamily b polypeptide 1) were down-regulated in B6
mice but up-regulated in D2 mice.
We also found that batches of oxidative stress relevant
genes represented different expression patterns between
B6 and D2. Nox4 (Nadph oxidase4), Homx1 (heme oxyge-
nase 1) and Saa(serum amyloid A) were up-regulated in
B6 mice but down-regulated in D2 mice, whereas,Hspa1b
(heat shock protein 1b) was down-regulated in B6 miceNutrition & Metabolism 2009, 6:43 http://www.nutritionandmetabolism.com/content/6/1/43
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and up-regulated in D2 mice. Moreover, a number of
genes involved in immune response and inflammation
signaling pathways such as T cell receptor signaling path-
way, leukocyte transendothelial migration, MHCI and
MHCII pathways were altered, and most of these genes
were up-regulated in B6 mice and down-regulated in D2
mice. Meanwhile, abundant apoptosis pathway genes
such as Bcl2-like 11, Bid (BH3 interacting domain death
agonist), Casp9 (caspase9) and Parp were also differen-
tially regulated.Bcl2-like 11 and Parp were up-regulated in
B6 mice and down-regulated in D2 mice. Bid and Casp9
were up-regulated in B6 mice but not altered in D2 mice.
Except for the above mentioned major pathways, genes
expression in adherens junction and purine metabolism
pathways was also differentially altered between B6 and
D2. The heatmap of modulated genes involved in func-
tional pathways was shown in Figure 2B. More informa-
tion about detailed pathways and their corresponding
genes were listed at Table S3 in Additional file 5.
Finally, to exclude the underlying differences prior to
feeding and the influence of age factor on the gene expres-
sion levels, we also compared genes expression between
B6 and D2 mice at the same time-point. We observed
Dynamic distribution of cholesterol and bile acids Figure 1
Dynamic distribution of cholesterol and bile acids. The x-axis represents each time point. The y-axis depicts concentra-
tions (mmol/l). Solid lines represent data in C57BL/6J (B6) mice and dashed lines represent data in DBA/2J (D2) mice. *P < 0.05 
(compared to 0th week), #P < 0.05 (compared to D2 mice); A: Total cholesterol (TC) in serum; B: Total cholesterol (TC) in 
bile; C: Non-HDL cholesterol in serum; D: HDL cholesterol in serum; E: Cholesterol esters (Cholsteryl oleate and linoleate) 
in serum; F: Total bile acids in bile.Nutrition & Metabolism 2009, 6:43 http://www.nutritionandmetabolism.com/content/6/1/43
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dominant expression patterns at all four time-points after
0 week. Most genes were up-regulated and few were
down-regulated. The result coincided with our above find-
ings (See Figure S3 in Additional file 6).
Confirmation by quantitative real time PCR
Fourteen representative gallstones or atherosclerosis rele-
vant genes which functioned in lipid metabolism, bile
acid synthesis, immune/inflammation and apoptosis
were selected to validate the results of the microarray anal-
ysis. The quantitative real time PCR results exhibited a
high coincidence with microarray results (Figure 3A, B,
and 3C).
TUNEL assay and Western blot
Under a fluorescence microscope, normal cells radiated
weak green light while apoptotic cells radiated strong
green light. Comprehensive counts showed that apoptotic
liver cells appeared increasingly in B6 mice from the 1st
week to the 21st week, however, this observation was not
found in D2 mice (Figure 4A and 4B). We also observed
that more apoptotic cells occurred at the 4th week when
Hierarchical cluster of differentially expressed genes between B6 and D2 mice Figure 2
Hierarchical cluster of differentially expressed genes between B6 and D2 mice. All the relevant genes are grouped 
by hierarchical clustering based on expression values (log2ratios) across all the samples. Ratios were calculated between 0 
week and the rest of time points in each mouse strains. Samples (Four time-points in C57BL/6J and DBA/2J, respectively) are 
displayed in columns and genes in rows. Gene expression is represented as a color, normalized across each row, with brighter 
red for higher values and brighter green for lower values. A. Heatmap of all the differentially expressed genes, most of which 
have different expression patterns between B6 and D2; B. Heatmap of genes involved in some major pathways, gene symbols 
listed to the right.Nutrition & Metabolism 2009, 6:43 http://www.nutritionandmetabolism.com/content/6/1/43
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gallstones were primarily formed, and the most apoptotic
cells appeared at the 21st  week when atherosclerotic
lesions were detected.
Several apoptosis, gallstones or atherosclerosis relevant
genes were selected to perform western-blot. As showed in
Figure 4C, the multifunctional protein Hspa1b was clearly
down-regulated in B6 mice and slightly up-regulated in
D2 mice. The expression of apoptosis marker protein Parp
was elevated in B6 mice and its activated form (89KD)
was also observed at 1,4,12 and 21 weeks, which was una-
ble to be detected in D2 mice. Cyp7a1, a key rate-limiting
enzyme of bile acid synthesis, showed decreased expres-
sion in B6 mice but increased expression in D2 mice.
Discussion
In the present study, we applied an animal model to
delineate the different responses to a high-fat/cholesterol
diet between B6 and D2 inbred mice, and uncover under-
lying genetic factors for these different responses.
We found an interesting and distinctive dynamic distribu-
tion of cholesterol and bile acid yields between B6 and D2
strains. We hypothesized that under the challenge of a
high-fat/cholesterol diet, D2 mice, which are resistant to
both gallstones and atherosclerosis, might prevent this
damage through an increased bile acid synthesis
approach; whereas, B6 mice might only avoid the damage
by their limited direct secretion of cholesterol into bile.
The hepatic genes expression profiles confirmed our
hypothesis, and provided more information by identify-
ing differentially expressed genes in pathways of lipid
metabolism, oxidative stress, immune response/inflam-
mation and apoptosis.
Abca1, Abcg5 and Abcg8 belong to the family of ABC trans-
porters, which can mediate secretion of excessive choles-
terol into bile and play important roles in consequent
gallstones or atherosclerosis [16]. Cytochrome P450 sub-
family members Cyp7a1 and Cyp8b1 were pivotal
enzymes of converting cholesterol into bile acids in bile
acid synthesis pathway [17]. After fed the high-fat/choles-
terol diet, Abca1,  Abcg5  and  Abcg8  genes expression
increased, but Cyp7a1 and Cyp8b1 decreased since the 1st
week in B6 mice. This indicated bile acid synthesis might
be depressed, excessive cholesterol might directly excrete
into bile and result in elevated bile TC in B6 mice. We
observed the highest fold-changes of Abcg5 and Abcg8 at
Real time PCR validation of regulated genes in microarray Figure 3
Real time PCR validation of regulated genes in microarray. Data were represented in three groups: A: cholesterol 
metabolism genes; B: inflammation and apoptosis genes; C: bile acid synthesis genes. The horizontal axis represents time points 
and the vertical axis represents log2ratio of each time point against 0 week in microarray and Real-time PCR data. Solid lines 
represent microarray data and dashed lines represent Real-time PCR data; marked with black triangles were data in C57BL/6J 
(B6) mice and marked with black circles were data in DBA/2J (D2) mice.Nutrition & Metabolism 2009, 6:43 http://www.nutritionandmetabolism.com/content/6/1/43
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the 4th week in B6, which were 9.5 and 6.3 folds respec-
tively. The distinct up-regulation of genes Abcg5 and Abcg8
might implicate hypersecretion of cholesterol into bile
and lead to gallstones formation. Interestingly, we noticed
the peak of bile TC level and primary gallstones formation
at the 4th week. Thereafter, gallstones were increasingly
formed; serum TC slightly lowered after the 12th week and
atherosclerotic lesions were not formed until the
21stweek. This might indicate a potential role of gallstones
formation in lowering serum cholesterol and protective
effects in atherosclerosis formation. To date, the xenobi-
otic substrates of Abcg5 and Abcg8 have been used for reg-
ulating gallstones formation and treatments of
cardiovascular disease, whereas the limited protective
mechanism may not confer the expected reduction in car-
diovascular risks in hypercholesterolemic patients [18]. In
contrast, we observed no alteration of Abca1, Abcg5 and
Abcg8 genes expression but increased levels of Cyp7a1 and
Cyp8b1 in D2 mice. Our results suggested that excessive
cholesterol might be eliminated by elevated bile acid syn-
thesis pathway in D2 mice. To our knowledge, transgenic
expression of Cyp7a1 might efficiently eliminate excessive
cholesterol and inhibit formation of gallstones and
atherosclerosis in mice [19]. In the present study, neither
gallstones nor atherosclerosis was found in D2 mice.
Therefore, modulation of enzymes and nuclear receptors
involved in bile acid synthesis might be potential pharma-
ceutical targets to control hypercholesterolemia and pre-
vent gallstones and atherosclerosis.
Modulation of Cyp7a1 may differ among inbred mice as a
result of diverse dietary and genetic factors. It is reported
that two high-fat diets contained safflower oil and 0.5%
sodium cholate with and without added cholesterol
(0.5%) resulted in differential expression levels of
Cyp7a1among nine inbred mice strains [20]. It is worth-
while to note that FXR (farnesoid × receptor) and LXR
(Liver × receptor) α are negative and positive regulators of
Cyp7a1. Cholic acid component is needed for FXR activa-
tion and that cholic acid, cholesterol and high fat are nec-
essary for activating LXRα. The different balance between
LXRα and FXR actions may lead to the diverse effects of
dietary cholesterol on Cyp7a1  expression [21]. In the
present study, both the transcript and protein levels of
Cyp7a1 decreased in B6 and increased in D2 mice, which
coincided with previous study [20]. Intriguingly, we
observed that FXR target gene Shp or Nr0b2 (short het-
erodimer partner, nuclear receptor subfamily 0, group B,
member 2) was clearly increased in B6 but not altered in
D2. This suggested that LXRα and FXR dominant actions
might differ between B6 and D2. Thus, Cyp7a1 might be
modulated by different nuclear receptors, resulting in
diverse regulation of cholesterol and subsequently varying
susceptibilities to gallstones and atherosclerosis. Besides
Cyp7a1 and Cyp8b1, many other cytochrome P450 sub-
family members such as Cyp2c44, Cyp2c55 and Cyp3a13
were also differently modulated. Further investigation in
their functions and regulators might help identifying
novel target genes of gallstones and atherosclerosis. In
addition, genes Soat1  and  Soat2  are known to encode
ACAT1 and ACAT2 enzymes in catalyzing the formation
of cholesteryl esters, an important process during athero-
sclerosis formation [22]. ACAT inhibitors have been
reported to increase bile acid synthesis by up-regulation of
Cyp7a1 expression in cultured rat hepatocytes [23]. In the
present study, we observed that genes Soat1  and Soat2
were differently regulated between B6 and D2. This might
provide a good demonstration that cholesteryl esters lev-
els differed, and susceptibilities to gallstones and athero-
sclerosis varied between B6 and D2. Taken together, our
findings suggested that the different distribution of cho-
lesterol, and varying susceptibilities to gallstones and
atherosclerosis might partly be attributable to diverse
modulation of lipid metabolism or bile acid synthesis
pathways.
Metabolic pathways involving cytochrome P450 enzymes
may initiate or modulate oxidative damage due to oxygen
radicals [24]. Moreover, oxidative stress may lead to
enhanced lipid peroxidation, the generation of hydroper-
oxides and other toxic compounds, which may contribute
TUNEL Assay (immunoflurescent labelling) and Western- blot analysis Figure 4
TUNEL Assay (immunoflurescent labelling) and 
Western-blot analysis. A: C57BL/6J mice, apoptotic liver 
cells radiating strong green light, normal cells radiating weak 
green light:DBA/2J mice, little apoptotic liver cells appeared. 
Time-course is shown from left to right; B: Apoptosis index 
(percentage) in C57BL/6J and DBA/2J mice. X-axis represent 
time-points, y-axis represents cell apoptosis percentage. *P < 
0.05 (compared to 0 week), #P < 0.05(compared to DBA/2J). 
C: Western blot analysis for selected proteins indicated pro-
teins expression was also differentially changed. Proteins reg-
ulation was seen for Hspa1b, Parp and Cyp7a1.Beta-Actin 
served as loading control.Nutrition & Metabolism 2009, 6:43 http://www.nutritionandmetabolism.com/content/6/1/43
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to the development of gallstones and atherosclerosis
[25,26]. The susceptibility to oxidative stress is reported to
differ among inbred mice, which may have long-term
implications in therapeutics and patient care if similar
inherited differences exist in humans [24]. In the present
study, abundant metabolic pathways genes as well as oxi-
dative stress related genes were identified differently regu-
lated between B6 and D2 mice. For instance, both mRNA
and protein levels of Hspa1b were depressed in B6 and
enhanced in D2 mice. Heat shock proteins have been con-
sidered to exert protective effects, due to their multifunc-
tion in anti-oxidative activity, cell survival, suppressing
apoptosis, regulating pro-inflammatory transcription fac-
tors [27]. It is coincident that gallstones and atherosclero-
sis have been regarded as inflammatory diseases [15,28].
In parallel, multiple inflammation relevant genes were
shown to represent different expression patterns between
B6 and D2 mice. Icam1 (intercellular adhesion
molecule1) and Vcam1 (vascular cell adhesion molecule
1) which are immunoglobin subfamily members and
important inflammatory factors during the development
and progression of atherosclerosis disease [29], were ele-
vated in B6 and lowered in D2 mice. Interestingly, inflam-
matory responses have been reported to repress bile acid
synthesis by negative regulating Cyp7a1 [30]. Altogether,
after fed the high-fat/cholesterol diet, B6 and D2 mice
might differ in abilities to dispose oxidative stress, induce
diverse inflammatory responses and subsequent varying
susceptibilities to gallstones or atherosclerosis. Our
microarray data might have provided a potential genetic
basis for this hypothesis, which might have long-term sig-
nificance in identifying novel pharmaceutical targets in
related diseases.
Cell apoptosis playing important roles in gallstones and
atherosclerosis has been well delineated. Hydrophilic
ursodeoxycholic acid (UDCA) exerts antiapoptotic effects
and has been used as a novel therapeutic agent for the
treatment of apoptosis-related liver diseases including
gallstones [31]. Endothelial cell apoptosis has been
reported to be responsible for the formation of coronary
thrombotic atherosclerotic plaques in rabbits [32]. In the
present study, microarray analysis revealed different regu-
lation of several pro-apoptotic or apoptotic genes between
B6 and D2. Furthermore, it was confirmed by QRT-PCR
and western-blot analysis. Using TUNEL Assay, diverse
hepatic apoptosis were observed between B6 and D2.
Meanwhile, increasing apoptotic cells were concomitant
with the progress of gallstones and atherosclerosis. It
seemed that ambiguous relationships might exist between
hepatic apoptosis and gallstones or atherosclerosis. More
extensive investigation in this issue may open a new ave-
nue to understand the mechanisms of gallstones and
atherosclerosis.
Conclusion
In all, we observed significantly different responses to a
high-fat/cholesterol diet between B6 and D2 mice, includ-
ing an interesting dynamic distribution of cholesterol in
serum and bile, hepatic apoptosis, gallstones and athero-
sclerosis formation. Using genome-wide microarray anal-
ysis, hepatic genes expression profiles revealed different
patterns in functional pathway groups including lipid
metabolism, oxidative stress, immune/inflammation
response and apoptosis, which might provide a genetic
basis for diverse responses between B6 and D2 mice. This
might provide us new insights into gallstones and athero-
sclerosis formation, and give us an opportunity to identify
candidate genes in associated diseases.
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Figure S3. Hierarchical cluster analysis. Hierarchical cluster analysis 
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